Mitochondrial subversion in cancer

Aditi Chatterjee1, Santanu Dasgupta, David Sidransky

  • 1Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, Baltimore, MD, USA.

Insights

Mitochondrial DNA (mtDNA) mutations are common in cancers and may contribute to tumor growth. This review explores mtDNA mutations, their role in cancer, and potential therapeutic strategies.

Area of Science:

  • Cellular Biology
  • Biochemistry
  • Oncology

Background:

  • Mitochondria are crucial for cellular energy production through oxidative phosphorylation.
  • Mutations in mitochondrial DNA (mtDNA), particularly in the D-loop region, are frequently observed in human cancers.
  • The impact of mtDNA mutations on cancer development varies based on mutation type and cellular proportion.

Purpose of the Study:

  • To review the prevalence and functional consequences of mtDNA mutations in tumorigenesis.
  • To explore the role of altered mtDNA in cancer progression and disease.
  • To discuss potential mitochondrial therapeutics and clinical applications.

Main Methods:

  • Review of existing literature on mitochondrial DNA mutations in cancer.
  • Analysis of studies investigating the biological impact of specific mtDNA mutations.
  • Examination of research on reactive oxygen species (ROS) production and tumor growth related to mtDNA alterations.

Main Results:

  • mtDNA mutations are identified in precancerous lesions, suggesting early involvement in transformation.
  • Introduction of mtDNA mutations in cancer cells can increase ROS production and promote tumor growth.
  • Altered mtDNA is implicated in cancer development, but specific functional significance requires further research.

Conclusions:

  • mtDNA mutations play a significant role in cancer development and progression.
  • Understanding specific mitochondrial mutations is key to developing targeted therapies.
  • Further research is needed to fully elucidate the functional significance of mtDNA mutations for clinical applications.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...